Sunday , 19 January 2025
0

No products in the cart.

Worldwide News Worldwide News
0

No products in the cart.

Home Health SEC Charges Ipsen Worker for Insider Trading Tied to $247M Epizyme Acquisition
Health

SEC Charges Ipsen Worker for Insider Trading Tied to $247M Epizyme Acquisition

September 11, 20241 Mins read44 Views
SEC Charges Ipsen Worker for Insider Trading Tied to $247M Epizyme Acquisition

Securities regulators say the role of Ipsen employee Dishant Gupta made him privy to details of the Epizyme acquisition. Gupta allegedly accumulated Epizyme shares while the deal was negotiated, then sold all of them hours after the transaction was announced.

The post SEC Charges Ipsen Worker for Insider Trading Tied to $247M Epizyme Acquisition appeared first on MedCity News.

Previous post Housing market in UK shows signs of recovery - RICS house price best since January 2020

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles

Health

AstraZeneca’s Calquence has expanded its FDA approval to include first-line treatment of...

ByJanuary 17, 2025

This interactive chart allows users to track public opinion on the Affordable...

ByJanuary 17, 2025
Health

By MIKE MAGEE In case you’ve missed it, sleep is all the...

ByJanuary 17, 2025
Health

Teladoc Health has joined Amazon’s Health Benefits Connector. Other companies offered through...

ByJanuary 17, 2025

Abous us

Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et magnis dis

Subscribe Now

    Subscribe to our mailing list to receives daily updates direct to your inbox!
    © Copyright 2022 Jellywp. All rights reserved powered by Jellywp.com